Pesquisa | Biblioteca Virtual em Saúde

1.

All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors.

Bree, Kelly K; Hensley, Patrick J; Lobo, Niyati; Brooks, Nathan A; Nogueras-Gonzalez, Graciela M; Guo, Charles C; Navai, Neema; Grossman, H Barton; Dinney, Colin P; Kamat, Ashish M.

J Urol ; 208(2): 284-291, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35770498

2.

Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design.

Matulay, Justin T; Li, Roger; Hensley, Patrick J; Brooks, Nathan A; Narayan, Vikram M; Grossman, H Barton; Navai, Neema; Dinney, Colin P N; Kamat, Ashish M.

J Urol ; 205(6): 1612-1621, 2021 06.

Artigo em Inglês | MEDLINE | ID: mdl-33502236

3.

The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin.

Brooks, Nathan A; Kokorovic, Andrea; Xiao, Lianchen; Matulay, Justin T; Li, Roger; Ranasinghe, Weranja K B; Nagaraju, Supriya; Shen, Yu; Gao, Jianjun; Navai, Neema; Dinney, Colin P N; Grossman, H Barton; Kamat, Ashish M.

BJU Int ; 128(1): 65-71, 2021 07.

Artigo em Inglês | MEDLINE | ID: mdl-33210440

4.

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.

Fernández, Mario I; Brausi, Maurizio; Clark, Peter E; Cookson, Michael S; Grossman, H Barton; Khochikar, Makarand; Kiemeney, Lambertus A; Malavaud, Bernard; Sanchez-Salas, Rafael; Soloway, Mark S; Svatek, Robert S; Vikram, Raghunandan; Vrieling, Alina; Kamat, Ashish M.

World J Urol ; 37(1): 3-13, 2019 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-30105454

5.

Reply by Authors.

Bree, Kelly K; Hensley, Patrick J; Lobo, Niyati; Brooks, Nathan A; Nogueras-Gonzalez, Graciela M; Guo, Charles C; Navai, Neema; Grossman, H Barton; Dinney, Colin P; Kamat, Ashish M.

J Urol ; 208(2): 290-291, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35770497

6.

Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.

Fernández, Mario I; Williams, Stephen B; Willis, Daniel L; Slack, Rebecca S; Dickstein, Rian J; Parikh, Sahil; Chiong, Edmund; Siefker-Radtke, Arlene O; Guo, Charles C; Czerniak, Bogdan A; McConkey, David J; Shah, Jay B; Pisters, Louis L; Grossman, H Barton; Dinney, Colin P N; Kamat, Ashish M.

BJU Int ; 119(5): 684-691, 2017 05.

Artigo em Inglês | MEDLINE | ID: mdl-27753185

7.

Reply by Authors.

Matulay, Justin T; Li, Roger; Hensley, Patrick J; Brooks, Nathan A; Narayan, Vikram M; Grossman, H Barton; Navai, Neema; Dinney, Colin P N; Kamat, Ashish M.

J Urol ; 205(6): 1620-1621, 2021 06.

Artigo em Inglês | MEDLINE | ID: mdl-33734859

8.

Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer.

Navai, Neema; Benedict, William F; Zhang, Guangcheng; Abraham, Alice; Ainslie, Nancy; Shah, Jay B; Grossman, H Barton; Kamat, Ashish M; Dinney, Colin P N.

Ann Surg Oncol ; 23(12): 4110-4114, 2016 11.

Artigo em Inglês | MEDLINE | ID: mdl-27387678

9.

Clinical outcomes of cT1 micropapillary bladder cancer.

Willis, Daniel L; Fernandez, Mario I; Dickstein, Rian J; Parikh, Sahil; Shah, Jay B; Pisters, Louis L; Guo, Charles C; Henderson, Samuel; Czerniak, Bogdan A; Grossman, H Barton; Dinney, Colin P; Kamat, Ashish M.

J Urol ; 193(4): 1129-34, 2015 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-25254936

10.

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

Culp, Stephen H; Dickstein, Rian J; Grossman, H Barton; Pretzsch, Shanna M; Porten, Sima; Daneshmand, Siamak; Cai, Jie; Groshen, Susan; Siefker-Radtke, Arlene; Millikan, Randall E; Czerniak, Bogdan; Navai, Neema; Wszolek, Matthew F; Kamat, Ashish M; Dinney, Colin P N.

J Urol ; 191(1): 40-7, 2014 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-23911605

11.

Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review.

Hoang, Anthony N; Agarwal, Piyush K; Walton-Diaz, Annerleim; Wood, Christopher G; Metwalli, Adam R; Kassouf, Wassim; Brown, Gordon A; Black, Peter C; Urbauer, Diana L; Grossman, H Barton; Dinney, Colin P N; Kamat, Ashish M.

BJU Int ; 113(5b): E28-33, 2014 May.

Artigo em Inglês | MEDLINE | ID: mdl-24053608

12.

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Garcia-Closas, Montserrat; Ye, Yuanqing; Rothman, Nathaniel; Figueroa, Jonine D; Malats, Núria; Dinney, Colin P; Chatterjee, Nilanjan; Prokunina-Olsson, Ludmila; Wang, Zhaoming; Lin, Jie; Real, Francisco X; Jacobs, Kevin B; Baris, Dalsu; Thun, Michael; De Vivo, Immaculata; Albanes, Demetrius; Purdue, Mark P; Kogevinas, Manolis; Kamat, Ashish M; Lerner, Seth P; Grossman, H Barton; Gu, Jian; Pu, Xia; Hutchinson, Amy; Fu, Yi-Ping; Burdett, Laurie; Yeager, Meredith; Tang, Wei; Tardón, Adonina; Serra, Consol; Carrato, Alfredo; García-Closas, Reina; Lloreta, Josep; Johnson, Alison; Schwenn, Molly; Karagas, Margaret R; Schned, Alan; Andriole, Gerald; Grubb, Robert; Black, Amanda; Jacobs, Eric J; Diver, W Ryan; Gapstur, Susan M; Weinstein, Stephanie J; Virtamo, Jarmo; Hunter, David J; Caporaso, Neil; Landi, Maria Teresa; Fraumeni, Joseph F; Silverman, Debra T.

Hum Mol Genet ; 20(21): 4282-9, 2011 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-21824976

13.

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.

Siefker-Radtke, Arlene O; Dinney, Colin P; Shen, Yu; Williams, Dallas L; Kamat, Ashish M; Grossman, H Barton; Millikan, Randall E.

Cancer ; 119(3): 540-7, 2013 Feb 01.

Artigo em Inglês | MEDLINE | ID: mdl-22914978

14.

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

Dinney, Colin P N; Fisher, Mark B; Navai, Neema; O'Donnell, Michael A; Cutler, David; Abraham, Alice; Young, Sophia; Hutchins, Beth; Caceres, Maria; Kishnani, Narendra; Sode, George; Cullen, Constance; Zhang, Guangcheng; Grossman, H Barton; Kamat, Ashish M; Gonzales, Marshall; Kincaid, Michael; Ainslie, Nancy; Maneval, Daniel C; Wszolek, Matthew F; Benedict, William F.

J Urol ; 190(3): 850-6, 2013 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-23507396

15.

Delayed ureterectomy after incomplete nephroureterectomy for upper tract urothelial carcinoma: pathologic findings and outcomes.

Abel, E Jason; Fisher, Mark B; Matin, Surena F; Kamat, Ashish M; Dinney, Colin P; Grossman, H Barton.

Int Braz J Urol ; 39(6): 817-22, 2013.

Artigo em Inglês | MEDLINE | ID: mdl-24456786

16.

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk.

Lin, Jie; Forman, Michele R; Wang, Jianming; Grossman, H Barton; Chen, Meng; Dinney, Colin P; Hawk, Ernest T; Wu, Xifeng.

Int J Cancer ; 131(8): 1892-903, 2012 Oct 15.

Artigo em Inglês | MEDLINE | ID: mdl-22261697

17.

Editorial Comment.

Grossman, H Barton.

J Urol ; 197(6): 1417, 2017 06.

Artigo em Inglês | MEDLINE | ID: mdl-28263732

18.

Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.

Grossman, H Barton; Stenzl, Arnulf; Fradet, Yves; Mynderse, Lance A; Kriegmair, Martin; Witjes, J Alfred; Soloway, Mark S; Karl, Alexander; Burger, Maximilian.

J Urol ; 188(1): 58-62, 2012 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-22583635

19.

Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial.

Kamat, Ashish M; Dickstein, Rian J; Messetti, Fabrizio; Anderson, Roosevelt; Pretzsch, Shanna M; Gonzalez, Graciela Noguera; Katz, Ruth L; Khanna, Abha; Zaidi, Tanweer; Wu, Xifeng; Grossman, H Barton; Dinney, Colin P.

J Urol ; 187(3): 862-7, 2012 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-22245325

20.

Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.

Lee, Eugene K; Herr, Harry W; Dickstein, Rian J; Kassouf, Wassim; Munsell, Mark F; Grossman, H Barton; Dinney, Colin P N; Kamat, Ashish M.

BJU Int ; 110(11 Pt B): E590-5, 2012 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-22758775

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors.

Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design.

The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin.

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.

Reply by Authors.

Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.

Reply by Authors.

Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer.

Clinical outcomes of cT1 micropapillary bladder cancer.

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review.

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

Delayed ureterectomy after incomplete nephroureterectomy for upper tract urothelial carcinoma: pathologic findings and outcomes.

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk.

Editorial Comment.

Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.

Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial.

Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.